Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will provide a keynote address at the Fierce Pharma Engage summit for pharma and biotech industry leaders entitled Breaking Barriers, Building Access: Communicating Bold Moves in Women’s Health Innovation. Ms. Johnson will discuss Daré’s approach for communicating its expanded business strategy to integrate 503B compounding as part of a dual-path approach to bring select Daré proprietary formulations to market, starting with its proprietary Sildenafil Cream formulation this year, and how strategic messaging plays a crucial role in helping stakeholders understand and embrace innovative business strategies.